Compare DexCom, Inc. (DXCM) vs LTC Properties Inc (LTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs LTC Properties Inc — how do they compare? DexCom, Inc. trades at $77.75 (market cap $28.06B), while LTC Properties Inc trades at $40.65 (market cap $2.05B). The key difference: DexCom, Inc. is far larger — about 13.7× LTC Properties Inc's market cap, and LTC Properties Inc pays a 5.69% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | LTC | |
|---|---|---|
Market Cap | $28.06B | $2.05B |
Sector | Health | Real Estate |
52-Week High | $89.53 | $40.36 |
52-Week Low | $54.84 | $33.98 |
Enterprise Value | $27.03B | $2.90B |
Dividend Yield | — | 5.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
LTC Properties (NYSE: LTC) trades at $40.54, up 1.27% on the day, with a bullish technical signal from moving averages. The healthcare REIT shows strong profitability with a 39.09% net income margin and consistent monthly dividends of $0.19 per share. Recent strategic moves include expanding its SHOP portfolio with $73M and $54M acquisitions in 2026 and enhancing its credit facility to $1.1B, signaling aggressive growth in senior housing.
The outlook is cautiously optimistic. The shift toward SHOP properties aims to materially change the growth profile by year-end 2026, supported by aging demographics. Key risks include recent earnings misses, rising debt levels, and execution of the portfolio transition. Analyst consensus leans Hold (59%), with mixed sentiment between strong fundamentals and near-term operational challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About LTC Properties Inc
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →
